Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
W911SR-26-R-HEAL · DEPT OF DEFENSE
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
This is a continuous, open announcement with no deadline unless specifically noted. (Please note this posting was formerly the Threat Agnostic Host-Directed Therapeutics/HEALER PBA. If a white paper was previously submitted under the HEALER name, then the submission is still valid for the revised an
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | $4.3M | n/a | 2026-07-01 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | $17.5M | n/a | 2026-06-30 |
| CERAMEDIX HOLDING, LLC | $4.5M | 18 | 2026-06-24 |
| TWIST BIOSCIENCE CORPORATION | $47K | 1 | 2026-06-24 |
| CHROMOLOGIC LLC | $4.5M | 18 | 2026-06-24 |
Questions
What is solicitation W911SR-26-R-HEAL?
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA), issued by DEPT OF DEFENSE, under NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)).
What do similar contracts close for?
Comparable closed awards in this category ran from $47K to $17.5M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.